AdaptHealth Corp
Provides home medical products direct to consumers and to healthcare providers.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying AdaptHealth's stock, projecting a price increase to $11.81.
Financial Health
AdaptHealth is generating solid revenue and cash flow, indicating a healthy financial position for growth.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring AHCO
At-Home Healthcare Stocks Explained | FDA Approval
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug simplifies treatment and reduces the need for hospital visits. This development highlights a broader trend toward at-home care, creating potential investment opportunities in companies that provide related medical devices and healthcare services.
Published: August 30, 2025
Explore BasketRiding The Regulatory Wave In Healthcare
The Department of Justice's investigation into UnitedHealth's Medicare billing practices has cast a shadow over the health insurance industry, potentially leading to stricter oversight. This creates an investment opportunity in companies that provide compliance and auditing services, which are essential for navigating a more complex regulatory environment.
Published: July 25, 2025
Explore BasketSilver Tsunami Solvers
Tap into companies serving the growing senior population's health, housing, and lifestyle needs. These carefully selected stocks represent businesses positioned to benefit from the substantial and increasing purchasing power of older demographics.
Published: June 18, 2025
Explore BasketRest & Recharge
Tap into the booming wellness economy with companies revolutionizing how we sleep and relax. These carefully selected stocks represent innovative leaders in sleep technology, relaxation services, and wellness solutions that are responding to our growing desire for better rest and recovery.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Homecare market tailwinds
Ageing populations and a move towards care at home can support demand, though revenue growth is subject to reimbursement and operational execution.
Services and scale
A mix of equipment sales and recurring services can provide stable cash flows if operations scale efficiently, but acquisition integration can affect margins.
Regulation & reimbursement
Payment policies and regulation materially affect profitability, so investors should monitor policy changes and payer relationships.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Thermo Fisher Scientific, Inc.
Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.
Intuitive Surgical, Inc.
A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties
